Beta3-adrenergic receptor gene studies in patients with Prader-Willi syndrome.
作者信息
Butler M G, Hedges L K, Babe K S
出版信息
Am J Med Genet. 1997 Oct 3;72(1):115-6. doi: 10.1002/(sici)1096-8628(19971003)72:1<115::aid-ajmg23>3.0.co;2-t.
Abstract
摘要
相似文献
1
Beta3-adrenergic receptor gene studies in patients with Prader-Willi syndrome.普拉德-威利综合征患者的β3-肾上腺素能受体基因研究。
Am J Med Genet. 1997 Oct 3;72(1):115-6. doi: 10.1002/(sici)1096-8628(19971003)72:1<115::aid-ajmg23>3.0.co;2-t.
2
[Molecular diagnosis of Prader-Willi and Angelman syndromes: methylation, cytogenetics and FISH analysis].普拉德-威利综合征和安吉尔曼综合征的分子诊断：甲基化、细胞遗传学及荧光原位杂交分析
Rev Med Chil. 2001 Apr;129(4):367-74.
3
Comparison of high resolution cytogenetics, fluorescence in situ hybridisation, and DNA studies to validate the diagnosis of Prader-Willi and Angelman's syndromes.高分辨率细胞遗传学、荧光原位杂交及DNA研究在普拉德-威利综合征和安吉尔曼综合征诊断验证中的比较
Arch Dis Child. 1995 May;72(5):397-402. doi: 10.1136/adc.72.5.397.
4
Diagnosis in Prader-Willi syndrome.普拉德-威利综合征的诊断
Arch Dis Child. 1994 Nov;71(5):441-2. doi: 10.1136/adc.71.5.441.
5
[Diagnosis of Prader-Willi syndrome by reverse transcriptase polymerase chain reaction].
Orv Hetil. 1998 Jul 12;139(28):1685-7.
6
[Rapid first-tier genetic diagnosis in patients with Prader-Willi syndrome].
Orv Hetil. 2018 Jan;159(2):64-69. doi: 10.1556/650.2018.30918.
7
Mutations of the P gene in oculocutaneous albinism, ocular albinism, and Prader-Willi syndrome plus albinism.眼皮肤白化病、眼白化病以及普拉德-威利综合征合并白化病中P基因的突变。
N Engl J Med. 1994 Feb 24;330(8):529-34. doi: 10.1056/NEJM199402243300803.
8
Deletion analysis of the imprinting center region in patients with Angelman syndrome and Prader-Willi syndrome by real-time quantitative PCR.通过实时定量PCR对天使综合征和普拉德-威利综合征患者印记中心区域进行缺失分析。
Genet Test. 2004 Winter;8(4):387-94. doi: 10.1089/gte.2004.8.387.
9
Prader-Willi syndrome: clinical and molecular cytogenetic investigations.
J Formos Med Assoc. 1996 Jun;95(6):474-9.
10
Birth prevalence of Prader-Willi syndrome in Australia.澳大利亚普拉德-威利综合征的出生患病率。
Arch Dis Child. 2003 Mar;88(3):263-4. doi: 10.1136/adc.88.3.263.
本文引用的文献
1
RESTING METABOLIC RATE IN PRADER-WILLI SYNDROME.普拉德-威利综合征的静息代谢率
Dysmorphol Clin Genet. 1990;4(1):27-32.
2
Molecular analysis of transforming growth factor beta in giant cell tumor of bone.骨巨细胞瘤中转化生长因子β的分子分析
Cancer Genet Cytogenet. 1993 Apr;66(2):108-12. doi: 10.1016/0165-4608(93)90237-g.
3
Prader-Willi syndrome: consensus diagnostic criteria.普拉德-威利综合征：共识诊断标准。
Pediatrics. 1993 Feb;91(2):398-402.
4
Childhood obesity: pathophysiology and treatment.儿童肥胖症：病理生理学与治疗
Acta Paediatr Jpn. 1995 Feb;37(1):1-6. doi: 10.1111/j.1442-200x.1995.tb03675.x.
5
Genetic variation in the beta 3-adrenergic receptor and an increased capacity to gain weight in patients with morbid obesity.β3 - 肾上腺素能受体的基因变异与病态肥胖患者体重增加能力增强。
N Engl J Med. 1995 Aug 10;333(6):352-4. doi: 10.1056/NEJM199508103330605.
6
A mutation in the beta 3-adrenergic receptor gene is associated with obesity and hyperinsulinemia in Japanese subjects.β3 - 肾上腺素能受体基因突变与日本人群的肥胖和高胰岛素血症相关。
Biochem Biophys Res Commun. 1995 Oct 13;215(2):555-60. doi: 10.1006/bbrc.1995.2500.
7
Prader-Willi syndrome.普拉德-威利综合征
Curr Probl Pediatr. 1984 Jan;14(1):1-55. doi: 10.1016/0045-9380(84)90043-4.
8
Clinical and cytogenetic survey of 39 individuals with Prader-Labhart-Willi syndrome.39例普拉德-威利综合征患者的临床与细胞遗传学调查
Am J Med Genet. 1986 Mar;23(3):793-809. doi: 10.1002/ajmg.1320230307.
9
Energy expenditure and body composition in Prader-Willi syndrome.普拉德-威利综合征中的能量消耗与身体组成
Metabolism. 1988 Feb;37(2):115-20. doi: 10.1016/s0026-0495(98)90003-8.
10
Molecular characterization of the human beta 3-adrenergic receptor.人β3 -肾上腺素能受体的分子特征
Science. 1989 Sep 8;245(4922):1118-21. doi: 10.1126/science.2570461.
Zotero 插件